Campath Lawsuit | 2025 Latest Updates

Campath Lawsuit Overview

The United States Food and Drug Administration (FDA) has mandated the inclusion of a black box warning for Campath due to the risk of serious adverse reactions. Patients treated with Campath are at a heightened risk for issues related to their arteries, including strokes and arterial dissection, particularly in individuals diagnosed with multiple sclerosis. These serious complications can lead to permanent disability and even death. The drug’s manufacturer is facing lawsuits from patients who have experienced these severe side effects.

Latest Campath Lawsuit Updates

November 28, 2018 – Patients prescribed Lemtrada, previously branded as Campath, may be entitled to compensation after suffering strokes or autoimmune complications allegedly linked to the drug’s use, according to Johnson Becker [1].

FDA Reports and Statistics

The FDA has specifically highlighted that patients treated with Campath are at a heightened risk for issues related to their arteries, including the possibility of strokes and the tearing of arteries, particularly in individuals diagnosed with multiple sclerosis.

“FDA is warning that rare but serious cases of stroke and tears of arteries in the head and neck have occurred in patients with multiple sclerosis (MS) shortly after they received Lemtrada (alemtuzumab),” the agency said. “These problems can lead to permanent disability and even death.”

“Patients or their caregivers should seek emergency treatment as soon as possible if the patient experiences signs or symptoms of a stroke or tears in the lining of the arteries, called arterial dissection,”

the agency said.

FDA is henceforth requiring all alemtuzumab-containing medications to carry its most severe “Black-Box Warning”, as well as a warning in the drugs’ Medication Guide [2], describing the risk of stroke and blood vessel wall tears.

Campath Injuries & Side Effects

Campath has been linked to several serious adverse reactions that can lead to severe injury or death.

• Stroke: Sudden neurological deficits due to interrupted blood flow to the brain
• Arterial dissection: Tears in the lining of arteries in the head and neck
• Permanent disability: Long-term or permanent loss of function or mobility
• Death: Fatal outcomes have been reported in severe cases

Arterial Dissection Symptoms

• Sudden numbness or weakness in the face or arms, especially if it occurs on only one side of the body
• Leg sudden numbness
• Walking sudden dizziness
• Body sudden confusion, trouble speaking, or difficulty understanding speech
• Sudden trouble seeing in one or both eyes
• Sudden trouble with walking, dizziness, or loss of balance or coordination
• Sudden severe headache or neck pain

Stroke Symptoms

• Trouble with speaking and understanding
• Paralysis or numbness of the face, arm or leg
• Sudden confusion
• One side of your mouth may droop when you try to smile
• Trouble with seeing in one or both eyes
• Headache
• Trouble with walking
• Loss of balance or loss of coordination

Do You Qualify for a Campath Lawsuit?

You may qualify for a Campath lawsuit if:

• You were prescribed and took Campath (alemtuzumab)
• You experienced serious side effects including stroke or arterial dissection
• Your injuries required medical treatment or hospitalization
• You can provide medical documentation linking your injuries to Campath

Evidence Required for a Campath Lawsuit

To strengthen your Campath lawsuit claim, you will need to provide:

• Medical records showing you were prescribed Campath
• Documentation of your diagnosis and treatment for stroke or arterial dissection
• Medical opinion linking your injuries to Campath usage
• Records of all related medical expenses and treatments

Damages You Can Recover

If successful in your Campath lawsuit, you may be able to recover compensation for:

• Medical expenses (past and future)
• Lost wages and diminished earning capacity
• Pain and suffering
• Permanent disability
• Punitive damages against the manufacturer

Related Article: MS Treatment Drug Zinbryta LawsuitSee the other dangerous drugs lawsuits that we’ve covered.

FDA Recommendation to Healthcare Professionals

FDA is advising anyone taking Campath to call a doctor right away if they experience any symptoms of stroke or arterial dissection:

“Healthcare professionals should advise patients at every Campath infusion to seek immediate emergency medical attention if they experience symptoms of ischemic or hemorrhagic stroke or cervicocephalic arterial dissection,” the agency said. “The diagnosis is often complicated because early symptoms such as headache and neck pain are not specific. Promptly evaluate patients who complain of symptoms consistent with these conditions.”

Statute of Limitations for Campath Lawsuits

Time limitations for filing a Campath lawsuit vary by state, typically ranging from 1-3 years from the date of injury or from when you discovered your injury was linked to Campath. It’s crucial to consult with an attorney as soon as possible to ensure your claim is filed within your state’s statutory deadlines.

FAQs

1. Has there been a class action filed on Campath?

No class action has been filed for Campath stroke or arterial dissection lawsuits. Cases are currently being handled as individual lawsuits rather than as part of a class action.

2. What Steps Should Individuals Take if They Believe They Have Experienced Adverse Effects From Campath?

The steps that individuals should take include seeking medical advice, documenting their symptoms and exposure, and contacting a legal professional to explore options for filing a claim or joining the Campath lawsuit.

3. What Evidence Is Being Presented to Support the Claims in the Campath Lawsuit?

Evidence being presented to support the claims includes medical records linking Campath to specific health issues, scientific studies, patient testimonies, and expert opinions on the drug’s risks and side effects.

4. How Has the Manufacturer of Campath Responded to the Allegations and the Ongoing Lawsuit?

The manufacturer has denied allegations, asserting the drug’s safety and efficacy, and disputes the claims by highlighting regulatory approvals and clinical trial results.

5. How long does a Campath lawsuit typically take to resolve?

Pharmaceutical litigation cases like Campath lawsuits can take anywhere from 1-3 years to resolve, depending on the complexity of your case and whether it settles or goes to trial.

6. Can I still file a lawsuit if my loved one died from Campath side effects?

Yes, the family of a deceased individual may be eligible to file a wrongful death lawsuit if their loved one died from complications related to Campath use.

7. What costs are involved in filing a Campath lawsuit?

Most pharmaceutical injury attorneys work on a contingency fee basis, meaning you pay nothing upfront and attorneys only get paid if they win your case.

Take Action Now: Time-Sensitive Legal Claims

Time is limited to pursue legal action for Campath-related injuries. Most states only allow 1-3 years from the date of injury to file a claim. Don’t delay in seeking the compensation you deserve.

At Schmidt & Clark, LLP, we offer:

• Free, confidential consultations to evaluate your case
• No upfront costs or fees
• Payment only if we win your case

Get a Free Campath Lawsuit Evaluation With Our Lawyers

The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Campath lawsuits. We are handling individual litigation nationwide and currently accepting Campath side effect cases in all 50 states.

Free Confidential Case Evaluation: Again, if you or a loved one has been injured by the side effects of Campath (alemtuzumab), you should contact our law firm immediately for a free case review by using the form below or dialing (866) 588-0600. You may be entitled to compensation by filing a Campath lawsuit against other pharmaceutical companies and we can help.

References:

[1] https://www.johnsonbecker.com/drug-injuries/lemtrada-campath-lawsuit/ 

[2] https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6236b0bc-82e9-4447-9a78-f57d94770269